Sessions

Familial hypercholesterolemia (FH) is a serious inherited disease that causes high cholesterol from childhood and increases the risk of cardiovascular events like heart attack and stroke. Unfortunately, many people with FH go undiagnosed.
FHabian is a digiphysical tool developed in Sweden to screen families for FH. The tool, developed by BCB Medical, makes it easy to invite all relatives of an index patient to be screened for FH. It enables seamless screening across healthcare regions, an overview of the number of people invited to screening and a number of people getting tested. It also provides an overview of the results and follow-up and communicates results of testing. FHabian has been in operation in the Stockholm Region since February 2021 and will soon expand to other regions in Sweden. With this innovative tool, it is hoped that more people with FH can be diagnosed and treated early, reducing their risk of serious cardiovascular events.

In order to improve the conditions for clinical research in Europe and to stimulate multinational clinical trials, CTIS - clinical trial information system - has been developed. It is a platform that is ONE single entrance to the clinical trial application and includes both the drug application and ethical approval. Several years of preparatory work and a one-year transition period have ended and from February 1, 2023 CTIS has been put into use and is mandatory to use. CTIS has been built and improved in close cooperation with users (industry and academia) and national pharmaceutical authorities and EMA, the European Medicines Agency.

Artificial intelligence (AI) has great potential to transform healthcare, making it more efficient, equitable, and safe. There are hundreds of AI-based tools available on the market today, yet few get adopted into clinical practice because of numerous barriers and challenges. This talk provides an overview of these hurdles and suggests 26 considerations synthesized from the literature, interviews, and workshop with stakeholders who have experience with the process of trying to adopt AI-based tools into clinical practice. We believe that as the barriers and challenges to AI adoption are addressed and overcome, AI will inevitably have a lasting impact on improving healthcare for all.

A practical approach to innovating and transforming healthcare through collaboration and acceleration of external companies and partners within Ramsay Santé 

As a free service you are invited to participate in a matchmaking event open to all delegates, presenters and exhibition participants. The aim of the event is to create win-win- situations and perhaps future collaborations between researchers, practitioners, patients and industry.The matchmaking is only available for conference delegates, investors and exhibitors.

To introduce regional implementation of technologies and digital services for well-being, ageing and care of older people at home in Finland in a governmental programme called ‘Smart Ageing and Care at Home’ (‘KATI’ for the Finnish Acronym) in 2020-2022. Technologies were acquired according to regional needs by usual procurement.In the workshop we present evaluation results and the Finnish model to implement technologies for ageing and care of older people at home (the KATI model). It was developed based on the experiences from the renewed service models in the regional projects. The model also includes the technology solutions that the regional projects integrated into their services.The participants will get knowledge about well-working service models, how technologies have been implemented successfully in the Satakunta Wellbeing Services County, as well as remaining challenges to be overcome. We will discuss with the participants how the model can be used in other regions. We and the participants will share experiences on implementing technology in home care services.We will present national plan for continuous collaboration and Finnish healthtech network for wellbeing services counties. Participants can share their expectations, possibilities and contributions to share good practices, and for international collaboration. They can also ask question about the Suvanto Care solution that was implemented in the Satakunta Wellbeing Services County.We expect discussion and feedback from participants of the KATI model and national coordination model.

How can digital therapeutics and software based medical devices play a role in healthcare innovation?
Using them as tools for innovating and rethinking treatment pathways, this creates leeway to improve efficiency for healthcare professionals and personalised care for patients. Katrina Laks shares the story of Migrevention, her own experience and the hurdles and possibilities for software-based medical devices in changing the mindset for the future of healthcare.

The EU Commission has with the EHDS fierce expectations regarding content and timing, pursuing a seemingly somewhat independent and self-determining approach. Denmark seeks to influence, that European interests, legislation, and standards complement each other, with standards of high quality and democratic legitimacy.

Schedule, track, and manage the entire breakdown and maintenance/calibration process, from opening a work order request to tracking all related operational costs. What's more? AI is at your fingertips, fixing the breakdown by just clicking a button in the app. RTLS  availability takes this CMMS to the next level, providing significant staff time savings by instantly accessing the real-time location of your assets. 

Providing seamless health care to homeless people and refugees is a challenge. Established solutions of medical informatics for information sharing often do not work in these settings. Innovative solutions addressing not only technical issues, but also social and ethical issues are needed for building a trustful digital ecosphere for this vulnerable population. In this workshop, we want to explore the problem in more detail and discuss possible solutions from several perspectives. The workshop is intended to be the starting point to build a European expert consortium that is motivated to further work on this problem and to explore, develop, implement and evaluate possible solutions.

In this seminar, Michelle will give an overview of human-centered Artificial Intelligence at AstraZeneca's Digital Health Research & Development.

The introduction of healthtech solutions has proven, by now, that it is having an impact in the main challenges that healthcare systems have in front of them-Democratization of care at a fraction of the cost. However, it is still challenging to assess the contribution each and every healthtech solution brings to society in an aggregated way. Would a metric like QALY (Quality-Adjusted Life year) and its use in healthtech help tackle this challenge?  Come and participate in a discussion, where we will share QALY results obtained for a variety of HealthTech solutions (updated results of a test asking the same question) as food for thought. Let’s discuss together: Is QALY viable for decision making to implement healthtech solutions?  -What are the uses QALY could have and what’s its potential? - Could an aggregated QALY help us measure impact?  Let’s find a path towards the adoption of Healthtech together!